Sonova Holding AG (XSWX:SOON) Cash Conversion Cycle: 158.16 (As of Mar. 2026)


XSWX:SOON Sonova Holding AG XSWX:SOON
90 GF Score
Price CHF194.40
GF Value CHF249.75
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sonova Holding AG Cash Conversion Cycle?

Sonova Holding AG XSWX:SOON -0.41% 90 Cash Conversion Cycle is 158.16 as of Mar. 2026. GuruFocus rates XSWX:SOON with a GF Score™ of 90/100 and a GF Value™ of CHF249.75 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Sonova Holding AG's Days Sales Outstanding for the six months ended in Mar. 2026 was 53.84.
Sonova Holding AG's Days Inventory for the six months ended in Mar. 2026 was 183.75.
Sonova Holding AG's Days Payable for the six months ended in Mar. 2026 was 79.43.
Therefore, Sonova Holding AG's Cash Conversion Cycle (CCC) for the six months ended in Mar. 2026 was 158.16.


Sonova Holding AG  (XSWX:SOON) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Sonova Holding AG Cash Conversion Cycle Related Terms


Sonova Holding AG Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Sonova Holding AG's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonova Holding AG Cash Conversion Cycle Chart

Sonova Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 134.93 123.31 135.97 141.37 133.58

Sonova Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 142.09 143.67 165.06 133.83 158.16

XSWX:SOON vs ABT, SYK, MDT: Cash Conversion Cycle Comparison

For the Medical Devices subindustry, Sonova Holding AG's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonova Holding AG Cash Conversion Cycle vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Sonova Holding AG's Cash Conversion Cycle falls into.


XSWX:SOON
90GF Score
Sonova Holding AG XSWX:SOON
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonova Holding AG Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Sonova Holding AG's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=55.89+163.61-85.92
=133.58

Sonova Holding AG's Cash Conversion Cycle for the quarter that ended in Mar. 2026 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=53.84+183.75-79.43
=158.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 158.16 mean?
Sonova Holding AG (XSWX:SOON) has a Cash Conversion Cycle of 158.16 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Sonova Holding AG and its competitors.
Is Sonova Holding AG's Cash Conversion Cycle too high?
Sonova Holding AG's current Cash Conversion Cycle is 158.16. The Medical Devices & Instruments industry median Cash Conversion Cycle is 156.96. Sonova Holding AG's value of 158.16 is 0.8% above this industry median. Overall, Sonova Holding AG has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's Cash Conversion Cycle compare to ABT and SYK?
Sonova Holding AG's Cash Conversion Cycle of 158.16 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 156.96. Sonova Holding AG's value of 158.16 is 0.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 156.96, based on 819 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current Cash Conversion Cycle of 158.16 is 0.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 156.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current Cash Conversion Cycle is 158.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (XSWX:SOON) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF249.75, compared to a current price of CHF194.40 — trading 22.2% below its estimated fair value. The current Cash Conversion Cycle is 158.16 and 0.8% above the Medical Devices & Instruments industry median of 156.96. Sonova Holding AG's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Sonova Holding AG (XSWX:SOON), the current Cash Conversion Cycle is 158.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonova Holding AG (XSWX:SOON) Overvalued in 2026?

Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued. The current stock price of CHF194.40 is trading 22.2% below its estimated GF Value™ of CHF249.75. GuruFocus considers Sonova Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:SOON:

  • Cash Conversion Cycle: 158.16
  • GF Value™: CHF249.75 vs. price of CHF194.40 (22.2% below fair value)
  • GF Score™: 90/100 with 3 warning signs
  • Industry Position: 0.8% above the Medical Devices & Instruments median

No single metric tells the full story. See the XSWX:SOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sonova Holding AG Business Description

Address Laubisrutistrasse 28, Stafa, CHE, CH-8712
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
90GF Score

Get the complete analysis for XSWX:SOON

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF194.40
Price
CHF249.75
GF Value